Adverum Biotechnologies
ADVM
ADVM
70 hedge funds and large institutions have $69.8M invested in Adverum Biotechnologies in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
6% less capital invested
Capital invested by funds: $74.1M → $69.8M (-$4.32M)
18% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 22
33% less call options, than puts
Call options by funds: $28K | Put options by funds: $42K
Holders
70
Holding in Top 10
4
Calls
$28K
Puts
$42K
Top Buyers
| 1 | +$2.07M | |
| 2 | +$1.31M | |
| 3 | +$700K | |
| 4 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
+$232K |
| 5 |
GWA
GGM Wealth Advisors
Baltimore,
Maryland
|
+$219K |
Top Sellers
| 1 | -$696K | |
| 2 | -$458K | |
| 3 | -$338K | |
| 4 |
BlackRock
New York
|
-$255K |
| 5 |
Morgan Stanley
New York
|
-$201K |
